Finally, as fibroblastic FAK activity in human PDAC tumours is an independent prognostic factor for DFS and OS, and mortality is mostly from metastatic disease (Siegel et al, 2017), we assessed the possible impact of fibroblastic FAK activity on tumour metastasis. The gene discussed is PTK2; the disease is neoplasm.